Pediococcus pentosaceus KABP-041 and Reduced FGID Severity

• Probiotic Properties of Bifidobacterium longum KABP042 and Pediococcus pentosaceus KABP041 Show Potential to Counteract Functional Gastrointestinal Disorders in an Observational Pilot Trial in Infants

  • 2022-01-12
  • Clinical Trial · n = 36
  • Frontiers in Microbiology 12
  • • E. Astó
    • P. Huedo
    • Tatiana Altadill
    • M. Aguiló García
    • M. Sticco
    • Marta Perez
    • Jordi Espadaler Mazo

  • PubMed: 35095783
  • DOI: 10.3389/fmicb.2021.741391

  2 Insights on

  • Reduced FGID Severity

  • High evidence

  an exploratory, observational, pilot study involving 36 infants diagnosed with at least one FGID (infant colic and/or functional constipation) showed the probiotic formula was well tolerated and FGID severity was significantly reduced after 14 days of treatment with the 2 strains.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes